Glycosyl compounds
Medchemexpress LLC PGLYRP4/PGRP-I beta 10ug | 10ug
PGLYRP4/PGRP-I beta protein is a model receptor that binds to the cell wall peptide peptidoglycan (PGN) in Gram-positive bacteria and exerts bactericidal activity by interfering with peptidoglycan biosynthesis Its antimicrobial properties extend to Gram-negative bacteria although it also binds to them PGLYRP4/PGRP-I beta Protein Human (HEK293 His) is the recombinant human-derived PGLYRP4/PGRP-I beta protein expressed by HEK293 with C-His labeled tag
Apexbio Technology LLC Anti-Amyloid Beta Solanezumab
Anti-Amyloid Beta Antibody (Solanezumab) (CAS No 955085-14-0) is a monoclonal antibody used in Alzheimer s research originating from Eli Lilly and Company It specifically targets amyloid beta plaques implicated in Alzheimer s pathogenesis by binding to soluble monomers thereby reducing plaque formation Solanezumab s action is primarily observed in the modulation of amyloid beta clearance mechanisms within the central nervous system In vitro activity typically occurs in the nanomolar range reflecting its high affinity and specificity for amyloid beta peptides It s commonly applied in cell models and animal studies to evaluate therapeutic potential particularly in transgenic mice expressing human amyloid precursor protein Additionally Solanezumab is prominent in drug screening processes for Alzheimer s therapeutics Experimental concentrations typically depend on the specific research design ensuring flexibility in dose-response assessments across different methodologies
Apexbio Technology LLC Anti-Amyloid Beta Solanezumab
Anti-Amyloid Beta Antibody (Solanezumab) (CAS No 955085-14-0) is a monoclonal antibody used in Alzheimer s research originating from Eli Lilly and Company It specifically targets amyloid beta plaques implicated in Alzheimer s pathogenesis by binding to soluble monomers thereby reducing plaque formation Solanezumab s action is primarily observed in the modulation of amyloid beta clearance mechanisms within the central nervous system In vitro activity typically occurs in the nanomolar range reflecting its high affinity and specificity for amyloid beta peptides It s commonly applied in cell models and animal studies to evaluate therapeutic potential particularly in transgenic mice expressing human amyloid precursor protein Additionally Solanezumab is prominent in drug screening processes for Alzheimer s therapeutics Experimental concentrations typically depend on the specific research design ensuring flexibility in dose-response assessments across different methodologies
Medchemexpress LLC IL-1 beta Human E6 10ug
IL-1 beta is a potent proinflammatory cytokine expressed by monocytes macrophages and dendritic cells IL-1 beta plays a key role in inflammation and immunologic reactions[1][2] IL-1 beta Protein Human (E6K His) is produced in E coli with a N-Terminal His-tag It consists of 269 amino acids (M1-S269)
=O | 5g | 256640135](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502199042.JPG-250.jpg)
eMolecules 102308-62-3 | 3-(P-NITROPHENYL)-DL-BETA-ALANINE | AstaTech | MFCD00187210 | 210.189 | C9H10N2O4 | 97.000 | NC(CC(O)=O)c1ccc(cc1)[N+]([O-])=O | 5g | 256640135
3-(P-NITROPHENYL)-DL-BETA-ALANINE | AstaTech | 102308-62-3 | MFCD00187210 | 210.189 | C9H10N2O4 | 97.000 | NC(CC(O)=O)c1ccc(cc1)[N+]([O-])=O | 5g | 256640135
Medchemexpress LLC FGFR-1 beta IIIc 100ug | 100ug
FGFR-1 alpha is a tyrosine-protein kinase receptor for fibroblast growth factor that is critical in embryonic development cell proliferation differentiation and migration GnRH is essential for mesodermal patterning axial organization skeletogenesis and nervous system development FGFR-1 beta (IIIc) Protein Human (HEK293 His-Avi) is the recombinant human-derived FGFR-1 beta expressed by HEK293 with C-Avi C-His labeled tag
Medchemexpress LLC Methyl B-D-glucopyra 10mM 1mL | 709-50-2 | 194.18 g/mol | C7H14O6 | 1 ML
Methyl β-D-glucopyranoside is a methyl glycoside reagent commonly used in organic synthesis and biocatalysis research. It is supplied as a ready-to-use 10 mM aqueous solution (1 mL) and is also available in multiple solid sizes for preparative use.
- Purity 99.91%.
- Molecular weight 194.18 g/mol.
- Chemical formula C7H14O6.
- CAS number 709-50-2.
- Storage: 4°C, sealed and away from moisture; in solvent -80°C (6 months), -20°C (1 month).
Medchemexpress LLC Latent transforming growth factor beta-3 (human) | >95.0% | 100UG
Recombinant human latent transforming growth factor beta-3 (latent TGF-β3) expressed in HEK293 cells and supplied as a lyophilized protein containing the latency-associated peptide. The product is formulated from filtered PBS with trehalose as a stabilizer and is intended for research applications involving TGF-β3 signaling, activation studies, and extracellular matrix interactions.
- Expressed in HEK293 cells with an N-terminal His tag.
- Purity greater than 95% by reducing SDS-PAGE.
- Predicted molecular weight 45.9 kDa; observed ~46-60 kDa by SDS-PAGE.
- Lyophilized formulation from 0.22 μm filtered PBS with trehalose protectant.
- Stored at -20°C; aliquot and freeze at -20°C or -80°C for extended storage.
Alkali Scientific 4 Nitrophenyl 2 acetamido 2 deoxy β D glucopyranoside, 1 G
4-Nitrophenyl 2-acetamido-2-deoxy-β-D-glucopyranoside (1g) is a chemical reagent used to investigate β-D-glucosidase and related enzyme activities in carbohydrate biochemistry. The compound, upon cleavage by β-D-glucosidase, releases p-nitrophenol, a product that can be quantified using spectrophotometric methods. This substrate is frequently used in enzyme assays for studying glycoside hydrolases, enzymes that play crucial roles in carbohydrate metabolism and cellular processes such as glycosylation and hydrolysis. The reagent is critical in research on metabolic pathways and the characterization of enzymes involved in sugar processing.